Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.

Holleman, Marscha S; Huygens, Simone A; Al, Maiwenn J; Kuppen, Malou C P; Westgeest, Hans M; van den Bergh, Alfonsus C M; Bergman, Andries M; van den Eertwegh, Alfonsus J M; Hendriks, Mathijs P; Lampe, Menuhin I; Mehra, Niven; van Moorselaar, Reindert J A; van Oort, Inge M; Somford, Diederik M; de Wit, Ronald; van de Wouw, Agnes J; Gerritsen, Winald R; Groot, Carin A Uyl-de

Holleman, Marscha S; Huygens, Simone A; Al, Maiwenn J; Kuppen, Malou C P; Westgeest, Hans M; van den Bergh, Alfonsus C M; Bergman, Andries M; van den Eertwegh, Alfonsus J M; Hendriks, Mathijs P; Lampe, Menuhin I; Mehra, Niven; van Moorselaar, Reindert J A; van Oort, Inge M; Somford, Diederik M; de Wit, Ronald; van de Wouw, Agnes J; Gerritsen, Winald R; Groot, Carin A Uyl-de.

Afiliação

Holleman MS; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. holleman@eshpm.eur.nl.
Huygens SA; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Al MJ; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Kuppen MCP; Department of Radiation Oncology, Maastro, Maastricht, The Netherlands.
Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
van den Bergh ACM; Department of Radiation Oncology, University Medical Centre, Groningen, The Netherlands.
Bergman AM; Division of Internal Medicine (MOD) and Oncogenomics, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van den Eertwegh AJM; Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam University Medical Centre, VU Amsterdam, Amsterdam, The Netherlands.
Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.
Lampe MI; Department of Urology, Medical Centre, Leeuwarden, The Netherlands.
Mehra N; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
van Moorselaar RJA; Department of Urology, VU University Medical Centre, Amsterdam, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
de Wit R; Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.
van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Centre, Venlo, The Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Groot CAU; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Drugs Real World Outcomes ; 9(2): 275-285, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35314962

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Drugs Real World Outcomes Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google